ACADIA PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.12 USD | +1.75% |
|
-11.73% | -51.71% |
| 05-10 | UBS Cuts Price Target on ACADIA Pharmaceuticals to $25 From $27, Keeps Buy Rating | MT |
| 05-10 | Oppenheimer Adjusts ACADIA Pharmaceuticals Price Target to $17 From $19, Maintains Perform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Other Biotechnology & Medical Research | +1.75% | -11.73% | -51.71% | -31.65% | -41.71% | 2.46B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ACAD Stock
- Charts ACADIA Pharmaceuticals Inc.
- Comparison Chart